UNITED THERAPEUTICS Corp Logo

UNITED THERAPEUTICS Corp

Develops therapies for chronic diseases and manufactures organs for transplantation.

UTHR | US

Overview

Corporate Details

ISIN(s):
US91307C1027
LEI:
Country:
United States of America
Address:
1000 SPRING ST, 20910 SILVER SPRING
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

United Therapeutics Corporation is a biotechnology company structured as a public benefit corporation (PBC). It focuses on the research, development, and commercialization of unique products and innovative therapies for patients with chronic and life-threatening conditions. The company's primary therapeutic areas include treatments for cardiovascular diseases, such as pulmonary arterial hypertension. United Therapeutics is also a leader in developing technologies to address the shortage of transplantable organs, including organ manufacturing and xenotransplantation, with the goal of providing a brighter future for patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all UNITED THERAPEUTICS Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for UNITED THERAPEUTICS Corp

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for UNITED THERAPEUTICS Corp via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Camurus Logo
Develops long-acting medicines for severe chronic diseases using advanced drug delivery.
Sweden CAMX
Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.
Japan 4575
Candel Therapeutics, Inc. Logo
Developing off-the-shelf viral immunotherapies to help the immune system fight solid tumors.
United States of America CADL
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel CANF
Cannovum Cannabis AG Logo
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany 27N0
Canopy Growth Corp Logo
Produces diverse cannabis products for medical and recreational markets globally.
United States of America CGC
Cantourage Group SE Logo
A European platform producing and distributing medical cannabis products to pharmacies.
Germany HIGH
CAPRICOR THERAPEUTICS, INC. Logo
Develops cell and exosome-based therapeutics for rare diseases like Duchenne muscular dystrophy.
United States of America CAPR
CAREGEN CO.,LTD. Logo
Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.
South Korea 214370
Caribou Biosciences, Inc. Logo
Uses CRISPR genome editing to create off-the-shelf CAR-T cell therapies for cancer.
United States of America CRBU

Talk to a Data Expert

Have a question? We'll get back to you promptly.